Enduring Material: Advancements in Diagnosis and Treatment of ATTR-CM
CME | CNE | CPE 1.50 Credits
Presented By
Johns Hopkins University School of Medicine and SPARK CME
Description
This program consists of an educational webinar. Participants will be able to view a recorded event that was originally hosted on November 19, 2025 that focuses on ways to effectively diagnose and treat ATTR-CM. The presentation lasts approximately 60 minutes, followed by approximately 20 minutes of Q&A with members of the program faculty.
Start Date:
December 10, 2025
End Date:
December 10, 2026
Who Should Attend
This activity is intended for neurologists, cardiologists, heart failure specialists, primary care physicians, geneticists, genetic counselors, radiologists, and nuclear medicine specialists.
Objectives
After participating in this activity, the learner will demonstrate the ability to:
- Recognize the diverse clinical presentations of ATTR-CM, and understand the factors contributing to a lack of recognition and diagnostic delays.
- Improve their knowledge of new and emerging therapies, their mechanisms of action and how patient preference, facilitated by shared decision making, may inform treatment decisions.
- Identify optimal referral pathways for patients with ATTR-CM, comprehend the importance of multidisciplinary care in improving outcomes for individuals with ATTR-CM, and improve awareness of common barriers to accessing specialized care, particularly for marginalized and underserved populations.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and SPARK CME. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this webinar activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Presenter and Provider Disclosure
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME.
| Name | Role | Relationship |
| Joban D. Vaishnav, MD | Activity Director/Planner/Faculty | Consulting fees with Pfizer and Alnylam Pharmaceuticals |
| Lily K. Stern, MD, FACC | Faculty | Grant/research support from Pfizer and Intellia, advisor status with Pfizer and BridgeBio and Hororaria from Alnylam Pharmaceuticals |
| Kevin M. Alexander, MD, FACC, FHFSA | Faculty | consulting fees from Alnylam Pharmaceuticals, Alexion, Novo Nordisk, Bayer Corporation, BridgeBio and Pfizer |
No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Acknowledgement
We wish to acknowledge the following company that has provided an educational grant in support of this activity: Pfizer.
Notice About Off-Label Use Presentations
The Johns Hopkins School of Medicine/ Advancements in Diagnosis and Treatment of ATTR-CM may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.
Johns Hopkins Statement Of Responsibility
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Copyright
All rights reserved – The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
Internet CME Policy
The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its internet site as an information resource and service for physicians, other health professionals, and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.
Disclaimer Statement
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This other activity – gamification quiz is produced for educational purposes only. Use of the Johns Hopkins School of Medicine name implies a review of the educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
Americans With Disabilities Act
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
Course Format – Method Of Participation
This webinar activity is expected to take approximately 80 minutes to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME credit.
Post-test
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME credit.
Faculty
Joban Vaishnav, MD, Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Director, Johns Hopkins University Comprehensive Center for Amyloidosis
Lily K. Stern, MD, FACC, Assistant Professor, Department of Cardiology, Cedars-Sinai Smidt Heart Institute, Advanced Heart Disease & Transplant Co-Director, Cardiac Amyloid Program
Kevin M. Alexander, MD, FACC, FHFSA, Assistant Professor of Medicine (Cardiovascular Medicine) Stanford University School of Medicine
Confidentiality Disclaimer for CME Activity Participant
I certify that I am participating in this Johns Hopkins School of Medicine activity for CME-accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g., Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-614-9900, e-mail: [email protected].
“The Office of Continuing Medical Education at the Johns Hopkins School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”
For CME questions, please contact the CME Office 410-955-2959 or email [email protected].
For CME Certificates, please call (410) 502-9636.
Johns Hopkins School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/ Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)
Click the “Begin Webinar” button above to begin.
In order to receive CME credits, a minimum score of 70% is needed. Once you complete the game, SPARK and the Johns Hopkins Office of Continuing Medical Education will process your credits through the Cloud CME portal. If you do not have an existing profile with Cloud CME from a previous program, a new profile is created for you automatically using the email address that you used to complete the form at the end of the quiz. If your email already exists in Cloud CME, your transcript will be updated with the credits. Please note that this process typically takes 4-6 weeks and your credits will not be available immediately. If you would also like a digital certificate of completion, please email [email protected].